Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $158.7900 (-0.86%) ($155.0300 - $162.2700) on Tue. Apr. 3, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.95% (three month average) | RSI | 28 | Latest Price | $158.7900(-0.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.2% a day on average for past five trading days. | Weekly Trend | LGND declines -3.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -0.975% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.975% (StdDev 1.95%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
Resistance Level | $168.63 | 5 Day Moving Average | $161.87(-1.9%) | 10 Day Moving Average | $163.48(-2.87%) | 20 Day Moving Average | $168.63(-5.84%) | To recent high | -13% | To recent low | 12.5% | Market Cap | $2.552b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |